Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2008

p> of two payments the Company expects to receive as a result of Guidant's

sale of its vascular intervention and endovascular solutions businesses

to Abbott and are not indicative of future operating results. Purchased

research and development is a highly variable charge based on valuation

assumptions. Management removes the impact of purchased research and

development from the Company's operating results to assist in assessing

the Company's operating performance and cash generated from operations.

The integration costs associated with the Company's acquisition of

Guidant do not reflect expected on-going future operating expenses. The

fair value adjustment related to the sharing of proceeds feature of the

Abbott stock purchase is a non-cash adjustment and is not indicative of

the Company's on-going operations. Accordingly, management excluded

these charges and gains for purposes of calculating these non-GAAP

measures to facilitate an evaluation of the Company's current operating

performance and a comparison to the Company's past operating


-- Restructuring-related charges - These adjustments primarily represent

severance, employee-related retention incentives, asset write-offs and

accelerated depreciation and other costs associated with the Company's

restructuring initiatives. These expenses are not indicative of the

Company's on-going operating performance and are excluded by management

in assessing the Company's operating performance, and are also excluded

from the Company's operating segments' measures of profit and loss used

for making operating decisions and assessing performance. Accordingly,

management excluded these charges for purposes of calculating these

non-GAAP measures to facilitate an evaluation of the Company's curren

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
2. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
3. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
4. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
5. Boston Scientific to Participate in UBS Global Life Sciences Conference
6. Boston Scientific Announces Court Decision
7. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
8. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
9. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
10. TechCFO Adds Gary Strickland as Partner in Boston Office
11. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
Post Your Comments:
(Date:10/9/2015)... , Oct. 9, 2015  DePuy Synthes Trauma* ... Flex with Q-PACK ®  Technology**, the only pre-hydrated ... trauma-related extremity procedures (foot and ankle, hand and wrist), ... was made here at the 2015 Orthopaedic Trauma Association ... a natural scaffold for new bone growth) and osteoinductive ...
(Date:10/9/2015)... ... October 09, 2015 , ... From blood to ... separating those cells from their surroundings for research, diagnostics, and cell therapy—also known ... address this, Ann Arbor-based startup Akadeum Life Sciences is developing a ...
(Date:10/8/2015)... ... October 08, 2015 , ... Researchers at the University of ... living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and ... June Choi and Ruikang Wang of the UW Department of Bioengineering, today in the ...
(Date:10/8/2015)... 2015  Sorrento Therapeutics, Inc. (NASDAQ:  SRNE; Sorrento), ... cancer and associated pain, announced today that Dr. Henry Ji, ... at the Aegis Capital Corporation 2015 Growth Conference ... Corporation 2015 Growth ConferenceDate:Friday, October 9, 2015Time:10:00 to ... The Wynn in Las Vegas, NV , ...
Breaking Biology Technology:
... VICL ) today announced the enhancement of ... de Guttadauro as Vice President, Corporate,Development. Prior ... Director of,Strategy at Biogen Idec since February 2007, ... that company,s Zevalin,the first radioimmunotherapy product approved for ...
... Mulia Pangkuan Negeri -, TORONTO, Aug. 20 ... on developing simple blood-based biomarker tests for the,early ... that its co-founder and Chief Scientific Officer, Dr. ... Negeri (DMPN), a State Honour,given by the Governor ...
... Poised for Market Launch, KIRKLAND, Wash., Aug. 20 ... for the treatment of arterial,disease, today announced that it ... has started building its sales team in preparation for ... Recently Pathway moved from its old 10,000-square-foot facility ...
Cached Biology Technology:
(Date:9/28/2015)... Sept. 28, 2015 CLEAR, the ... its expedited traveler service is coming to ... travel, bringing a frictionless experience, serious speed ... "CLEAR offers our travelers an expedited ... said Jim Smith , Executive Director, ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
(Date:9/10/2015)... 10, 2015 Report Details The ... delivered upon previous expectations of revenues, consumer adoption and ... year in which wearables begin to achieve that mass ... the main reasons is the entrance of Apple to ... SmartWatches market, but the overall size of the wearable ...
Breaking Biology News(10 mins):
... LA JOLLA, Calif., September 25 2013 A new ... called medulloblastoma has been developed by researchers at Sanford-Burnham ... cellsthe cells that are critical for maintaining tumor growthand ... are essential for tumor progression. The process destroys the ...
... how their meat is sourced, with animal welfare ... many purchases. Unfortunately, many widely-used livestock production methods ... from the University of Cambridge has identified what ... silvopastoral systems which include shrubs and trees with ...
... , Sept. 25, 2013   GenoVive , an innovator ... against the emerging "globesity" epidemic through its development of ... on each individual,s unique metabolism.  "Weight Loss Designed by ... to customize an all natural meal and exercise program ...
Cached Biology News:
Complement C1r [Human]...
... FHS-LVF and CVD-Diffuse We've combined our ... to create the world's first notch filter ... bandpass. Each filter features an excellent transmission ... These filters -- with interference coatings applied ...
... Synthetic peptide derived from an internal region ... target of rapamycin FRAP RAFT1 RAPT1). ... On Western blots it identifies the ... Human (positive control: HEK293 cell lysates). Based ...
Biology Products: